Pan C, Xu A, Ma X, Yao Y, Zhao Y, Wang C
Front Oncol. 2023; 13:1226118.
PMID: 37904877
PMC: 10613467.
DOI: 10.3389/fonc.2023.1226118.
Martinez Barreiro M, Vazquez Alberdi L, De Leon L, Avellanal G, Duarte A, Anzibar Fialho M
Biology (Basel). 2023; 12(10).
PMID: 37887034
PMC: 10604841.
DOI: 10.3390/biology12101324.
Clay M, Pinto E, Cline C, Tran Q, Lin T, Dyer M
JCO Precis Oncol. 2020; 3.
PMID: 32923859
PMC: 7446418.
DOI: 10.1200/PO.19.00163.
Wang M, Guo J, Zhao Y, Wang J
Aging (Albany NY). 2020; 12(16):16099-16110.
PMID: 32855360
PMC: 7485739.
DOI: 10.18632/aging.103566.
Bhat A, Syed N, Therachiyil L, Nisar S, Hashem S, Macha M
Int J Mol Sci. 2020; 21(2).
PMID: 31952355
PMC: 7013445.
DOI: 10.3390/ijms21020569.
HOXA5 determines cell fate transition and impedes tumor initiation and progression in breast cancer through regulation of E-cadherin and CD24.
Teo W, Merino V, Cho S, Korangath P, Liang X, Wu R
Oncogene. 2016; 35(42):5539-5551.
PMID: 27157614
PMC: 5073039.
DOI: 10.1038/onc.2016.95.
Opening tight junctions may be key to opening the blood-prostate barrier.
Shang Y, Cui D, Yi S
Med Sci Monit. 2014; 20:2504-7.
PMID: 25448323
PMC: 4262056.
DOI: 10.12659/MSM.890902.
Anti-apoptotic effect of claudin-1 on TNF-α-induced apoptosis in human breast cancer MCF-7 cells.
Liu Y, Wang L, Lin X, Wang J, Yu J, Miao Y
Tumour Biol. 2012; 33(6):2307-15.
PMID: 22941467
DOI: 10.1007/s13277-012-0493-1.
Specificity of interaction between clostridium perfringens enterotoxin and claudin-family tight junction proteins.
Mitchell L, Koval M
Toxins (Basel). 2011; 2(7):1595-611.
PMID: 22069652
PMC: 3153273.
DOI: 10.3390/toxins2071595.
On the interaction of Clostridium perfringens enterotoxin with claudins.
Veshnyakova A, Protze J, Rossa J, Blasig I, Krause G, Piontek J
Toxins (Basel). 2011; 2(6):1336-56.
PMID: 22069641
PMC: 3153257.
DOI: 10.3390/toxins2061336.
Claudin 1 in breast tumorigenesis: revelation of a possible novel "claudin high" subset of breast cancers.
Myal Y, Leygue E, Blanchard A
J Biomed Biotechnol. 2010; 2010:956897.
PMID: 20490282
PMC: 2871677.
DOI: 10.1155/2010/956897.
Tight junctions: a barrier to the initiation and progression of breast cancer?.
Brennan K, Offiah G, McSherry E, Hopkins A
J Biomed Biotechnol. 2009; 2010:460607.
PMID: 19920867
PMC: 2777242.
DOI: 10.1155/2010/460607.
Altered serotonin physiology in human breast cancers favors paradoxical growth and cell survival.
Pai V, Marshall A, Hernandez L, Buckley A, Horseman N
Breast Cancer Res. 2009; 11(6):R81.
PMID: 19903352
PMC: 2815543.
DOI: 10.1186/bcr2448.
Tight junctions and the modulation of barrier function in disease.
Forster C
Histochem Cell Biol. 2008; 130(1):55-70.
PMID: 18415116
PMC: 2413111.
DOI: 10.1007/s00418-008-0424-9.
Expression patterns of claudin family of tight-junction proteins in the mouse prostate.
Sakai N, Chiba H, Fujita H, Akashi Y, Osanai M, Kojima T
Histochem Cell Biol. 2007; 127(4):457-62.
PMID: 17260152
DOI: 10.1007/s00418-007-0269-7.
Large DNA palindromes as a common form of structural chromosome aberrations in human cancers.
Tanaka H, Bergstrom D, Yao M, Tapscott S
Hum Cell. 2006; 19(1):17-23.
PMID: 16643603
DOI: 10.1111/j.1749-0774.2005.00003.x.
Antimetastatic gene expression profiles mediated by retinoic acid receptor beta 2 in MDA-MB-435 breast cancer cells.
Wallden B, Emond M, Swift M, Disis M, Swisshelm K
BMC Cancer. 2005; 5:140.
PMID: 16255778
PMC: 1283145.
DOI: 10.1186/1471-2407-5-140.
The transcription factors Slug and Snail act as repressors of Claudin-1 expression in epithelial cells.
Martinez-Estrada O, Culleres A, Soriano F, Peinado H, Bolos V, Martinez F
Biochem J. 2005; 394(Pt 2):449-57.
PMID: 16232121
PMC: 1408675.
DOI: 10.1042/BJ20050591.
Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study.
Tokes A, Kulka J, Paku S, Szik A, Paska C, Novak P
Breast Cancer Res. 2005; 7(2):R296-305.
PMID: 15743508
PMC: 1064136.
DOI: 10.1186/bcr983.
The organization of tight junctions in epithelia: implications for mammary gland biology and breast tumorigenesis.
Itoh M, Bissell M
J Mammary Gland Biol Neoplasia. 2004; 8(4):449-62.
PMID: 14985640
PMC: 2933220.
DOI: 10.1023/B:JOMG.0000017431.45314.07.